NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

COVID-19 Pandemic Lockdown Effect in Adolescents and Young Adults With Type 1 Diabetes: Positive Results of an Unpreceded Challenge for Telemedicine and Patient Self-management

NCT04669912

CompletedN/A

Sponsor: Centre Hospitalier Sud Francilien

Conditions: Type 1 Diabetes

Interventions: glucose control and sensor usage

Countries: France

Lockdown resulting from the COVID-19 pandemic was an unpreceded model of the impact of lifestyle on chronic diseases, especially for adolescents and young adults with type 1 diabetes (T1D) whose lifestyle is known to strongly impact disease management. The investigators aimed to assess changes in self-monitoring and glycemic control in this population before, during, and after the two-month French lockdown. Te investigators hypothesized an improvement in glucose control and glucose sensor usage. The protocol will include all patients with T1D from 13 to 25 years old using a flash glucose monitoring related to the LibreView cloud platform. The primary outcome, evolution of percentage of glucose time in range 70-180 mg/dL (TIR), and secondary outcomes (glucose management indicator GMI, time spent below range TBR, and sensor usage) will be analyzed with a linear mixed-effects regression model.

Eligibility overview

Sex: ALL

Age: 13 Years to 25 Years

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Type 1 diabetes
* Age between 13 and 25 years
* use of a flash glucose monitoring related to the LibreView cloud platform
* patients follow-up by the diabetes department of Hopital Sud Francilien or the diabetes department of Hôpital Bicêtre.
* patient informed of the study and not having objected to it.

Exclusion Criteria:

* patients out of France during lockdown
* other type of diabetes
* Duration of diabetes of less than one year
* patient aged under 13 years or above 26 years old

Locations (1)

Corbeil-Essonnes, France, France